this year promises to be another filled with interesting conversations, dynamic dialogues and learning, lots of learning – across the...

ASCO has published their annual report on progress against cancer – the report highlights the most important clinical research advances...

rapid advances of the molecular pathways that underlie cancer combined with an expansion of the tools at our disposal to diagnose and...

cancer is a global problem, with countries worldwide struggling to keep pace with the speed of innovation, budgetary constraints and...

do we want an innovative canada or are we ok with a balanced-book kind of canada? if that isn’t the million dollar question these days....

on september 5.2018 health canada gave a notice of compliance [NOC] for tisagenlecleucel [kymriah]. it was the first chimeric antigen...

biosimilars provide an opportunity to manage the incoming innovation in oncology and to create a more sustainable healthcare system. but...

car t-cell therapy is the next big cancer treatment hitting the canadian cancer treatment landscape— with one recently approved car...

the arrival of car t-cell therapy is disrupting the canadian healthcare system, but it has also offered an opportunity for canada to...

the cancer collaborative hosted a webinar on June 19 2019 with jatinder harchowal from the NHS whereby he provided insight into the NHS’...

patients are eager for participatory discussions and those who participate in those discussions demonstrate high rates of knowledge...

from the ASCO plenary june 1, 2019 there is a large volume of evidence that racial disparities exist in cancer outcomes and access to...